Trade Summary
On Nov 18, 2026, Burns John Thomas, CFO, sold $73.5K of SELLAS Life Sciences Group, Inc. (SLS) across 1 transaction. The filing covers Common Stock and reflects net selling of $73.5K. Reported prices ranged from $19.18. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- SELLAS Life Sciences Group, Inc.
- Ticker Symbol
- SLS
- CIK
- 0001390478
Insider Information
- Role
- CFO
- Location
- NEW YORK, NY
Filing Details
- Filing Date
- Nov 20, 2026
- Transaction Date
- Nov 18, 2026
- Accession Number
- 0001104659-26-130720
- Form Type
- 4
- Net Trading Amount
- -$73.5K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Nov 18, 2026 | Common Stock | 3,831 | $19.18 | Sale | $73.5K |
Want live alerts when Burns John Thomas trades again?
Download Insider Trades to track SLS, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)Represents shares sold to satisfy the Reporting Person's tax withholding obligation in connection with the performance based vesting of certain previously granted restricted stock units upon meeting the primary endpoint in the Issuer's Phase 3 REGAL study. These sales are mandated as part of the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.